Update on the endocannabinoid system as an anticancer target

Bibliography

• Bisogno T, Ligresti A, Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol Biochem Behav 2005;81:224-38
   PubMed Web of Science ®Google Scholar
• Devane WA, Dysarz FA, Johnson MR, Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-13
   PubMed Web of Science ®Google Scholar
• Matsuda LA, Lolait SJ, Brownstein MJ, Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-4
   PubMed Web of Science ®Google Scholar
• Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-5
   PubMed Web of Science ®Google Scholar
• Howlett AC, Barth F, Bonner TI, Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202
   PubMed Web of Science ®Google Scholar
• Suarez J, Bermudez-Silva F, Mackie K, Immunohistochemical description of the endogenous cannabinoid systemin the rat cerebellum and functionally related nuclei. J Comp Neurol 2008;509:400-21
   PubMedGoogle Scholar
• Benito C, Nunez E, Tolon RM, Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 2003;23(35):11136-41
   PubMedGoogle Scholar
• Benito C, Tolon RM, Pazos MR, Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol 2008;153(2):277-85
   PubMedGoogle Scholar
• Ryberg E, Larsson N, Sjogren S, The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007;152:1092-101
   PubMed Web of Science ®Google Scholar
• Baker D, Pryce G, Davies WL, Hiley CR. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 2006;27(1):1-4
   PubMed Web of Science ®Google Scholar
• Liu J, Gao B, Mirshahi F, Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 2000;346:835-40
   PubMed Web of Science ®Google Scholar
• Rueda D, Galve-Roperh I, Haro A, Guzman M. The CB1 cannabinoid receptor is coupled to the activation of c-Jun N terminal kinase. Mol Pharmacol 2000;58:814-20
   PubMed Web of Science ®Google Scholar
• Gomez del Pulgar T, Velasco G, Guzman M. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 2000;347:369-73
   PubMed Web of Science ®Google Scholar
• Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003;4(11):873-84
   PubMedGoogle Scholar
• Bermudez-Silva FJ, Viveros MP, McPartland JM, Rodriguez de Fonseca F. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav 2010;95(4):375-82
   PubMedGoogle Scholar
• Bifulco M, Di Marzo V. The endocannabinoid system as a target for the development of new drugs for cancer therapy. Nat Med 2002;8:547-50
   PubMed Web of Science ®Google Scholar
• Bifulco M, Laezza C, Pisanti S, Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 2006;148:123-35
   PubMed Web of Science ®Google Scholar
• Grimaldi C, Pisanti S, Laezza C, Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res 2006;312:363-73
   PubMed Web of Science ®Google Scholar
• Bifulco M, Laezza C, Valenti M, A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J 2004;18(13):1606-8
   PubMedGoogle Scholar
• Bifulco M, Laezza C, Gazzerro P, Pentimalli F. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion. Oncol Rep 2007;17(4):813-16
   PubMedGoogle Scholar
• Laezza C, Pisanti S, Malfitano AM, Bifulco M. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway. Endocr Relat Cancer 2008;15(4):965-74
   PubMedGoogle Scholar
• Preet A, Ganju RK, Groopman JE. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 2008;27(3):339-46
   PubMedGoogle Scholar
• Galve-Roperh I, Sanchez C, Cortes ML, Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000;6(3):313-19
   PubMedGoogle Scholar
• Bifulco M, Laezza C, Portella G, Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J 2001;15:2745-7
   PubMed Web of Science ®Google Scholar
• Qamri Z, Preet A, Nasser MW, Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. 2009;8(11):3117-29
   Google Scholar
• Casanova ML, Blazquez C, Martinez-Palacio J, Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 2003;111:43-50
   PubMed Web of Science ®Google Scholar
• Carracedo A, Gironella M, Lorente M, Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 2006;66:6748-55
   PubMed Web of Science ®Google Scholar
• Blazquez C, Carracedo A, Barrado L, Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 2006;20:2633-5
   PubMed Web of Science ®Google Scholar
• Parolaro D, Massi P. Cannabinoids as potential new therapy for the treatment of gliomas. Expert Rev Neurother 2008;8(1):37-49
   PubMedGoogle Scholar
• Marczylo TH, Lam PMW, Amoako AA, Konj JC. Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. Anal Biochem 2010;400(2):155-62
   PubMedGoogle Scholar
• Romero J, Orgado JM. Cannabinoids and neurodegenerative diseases. CNS Neurol Disord Drug Targets 2009;8(6):440-50
   PubMedGoogle Scholar
• Petersen G, Moesgaard B, Schmid PC, Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue. J Neurochem 2005;93:299-309
   PubMed Web of Science ®Google Scholar
• Pagotto U, Marsicano G, Fezza F, Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab 2001;86:2687-96
   PubMed Web of Science ®Google Scholar
• Nithipatikom K, Endsley MP, Isbell MA, 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res 2004;64:8826-30
   PubMed Web of Science ®Google Scholar
• Ligresti A, Bisogno T, Matias I, Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 2003;125:677-87
   PubMed Web of Science ®Google Scholar
• Schmid PC, Wold LE, Krebsbach RJ, Anandamide and other N-acylethanolamines in human tumors. Lipids 2002;37:907-12
   PubMed Web of Science ®Google Scholar
• Cianchi F, Papucci L, Schiavone N, Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 2008;14(23):7691-700
   PubMedGoogle Scholar
• Michalski CW, Oti FE, Erkan M, Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer 2008;122:742-50
   PubMed Web of Science ®Google Scholar
• Guida M, Ligresti A, De Filippis D, The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma. Endocrinology 2010;151(3):921-8
   PubMedGoogle Scholar
• Di Marzo V, Deutsch DG. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis 1998;5(6 Pt B):386-404
   PubMedGoogle Scholar
• Nomura DK, Long JZ, Niessen S, Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 2010;140(1):49-61
   PubMedGoogle Scholar
• Thors L, Bergh A, Persson E, Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4. PLoS One 2010;5(8):e12275
   Google Scholar
• Endsley M, Thill R, Choudhry I, Expression and function of fatty acid amide hydrolase in prostate cancer. Int J Cancer 2008;123:1318-26
   PubMed Web of Science ®Google Scholar
• Di Marzo V, Melck D, Orlando P, Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J 2001;358:249-55
   PubMed Web of Science ®Google Scholar
• Petrosino S, Di Marzo V. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs 2010;11(1):51-62
   PubMedGoogle Scholar
• Naidu PS, Kinsey SG, Guo TL, Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase. J Pharmacol Exp Ther 2010;334(1):182-90
   PubMedGoogle Scholar
• Gustafsson K, Wang X, Severa D, Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. Int J Cancer 2008;123(5):1025-33
   PubMedGoogle Scholar
• Joseph J, Niggemann B, Zaenker KS, Entschladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 2004;53(8):723-8
   PubMedGoogle Scholar
• Giuliano M, Pellerito O, Portanova P, Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARg. Biochimie 2009;91(4):457-65
   PubMedGoogle Scholar
• Czifra G, Varga A, Nyeste K, Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol 2009;135(4):507-14
   PubMedGoogle Scholar
• Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010;58(9):1017-30
   PubMedGoogle Scholar
• Parfienuk A, Flisiak R. Role of cannabinoids in chronic liver disease. World J Gastroenterol 2008;14:6109-14
   PubMedGoogle Scholar
• Luca T, Di Benedetto G, Scuderi MR, The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro. Molecular and Cellular Pharmacology. Eur J Pharmacol 2009;616:16-21
   PubMedGoogle Scholar
• De Jesus ML, Hostalot C, Garibi JM, Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas. Neurochem Int 2010;56(6-7):829-33
   PubMedGoogle Scholar
• Schley M, Stander S, Kerner J, Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Res Bull 2009;79(5):333-7
   PubMedGoogle Scholar
• Caffarel MM, Andradas C, Mira E, Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer 2010;9:196
   PubMed Web of Science ®Google Scholar
• Miyato H, Kitayama J, Yamashita H, Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. J Surg Res 2009;155(1):40-7
   PubMedGoogle Scholar
• Oesch S, Dagmar W, Wachtel M, Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther 2009;8(7):1838-45
   PubMedGoogle Scholar
• Cianchi F, Papucci L, Schiavone N, Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 2008;14(23):7691-700
   PubMedGoogle Scholar
• Caffarel MM, Sarrio D, Palacios J, Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res 2006;66(13):6615-21
   PubMedGoogle Scholar
• Marincsak R, Toth BI, Czifra G, Increased expression of TRPV1 in squamous cell carcinoma of the human tongue. Oral Dis 2009;15(5):328-35
   PubMedGoogle Scholar
• DeMorrow S, Francis H, Gaudio E, The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol 2008;295:G1150-8
   PubMed Web of Science ®Google Scholar
• Cozzolino R, Cali G, Bifulco M, Laccetti P. A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. Invest New Drugs 2010;28(2):115-23
   PubMedGoogle Scholar
• Rukiyah TVD. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes. Mol Carcinog 2009;48(8):724-32
   PubMedGoogle Scholar
• De Petrocellis L, Melck D, Palmisano A, The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 1998;95(14):8375-80
   PubMedGoogle Scholar
• Melck D, De Petrocellis L, Orlando P, Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 2000;141(1):118-26
   PubMedGoogle Scholar
• Laezza C, Pisanti S, Crescenzi E, Bifulco M. Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. FEBS Lett 2006;580(26):6076-82
   PubMedGoogle Scholar
• Olea-Herrero N, Vara D, Malagarie-Cazenave S, Diaz-Laviada I Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2. Br J Cancer 2009;101(6):940-50
   PubMedGoogle Scholar
• Mimeault M, Pommery N, Henichart JP. Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines. Int J Cancer 2003;106(1):116-24
   PubMedGoogle Scholar
• Xian XS, Park H, Cho YK, Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells. J Cell Biochem 2010;110:321-32
   PubMed Web of Science ®Google Scholar
• McKallip RJ, Lombard C, Fisher M, Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002;100(2):627-34
   PubMedGoogle Scholar
• Jacobsson SO, Wallin T, Fowler CJ. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther 2001;299(3):951-9
   PubMedGoogle Scholar
• Massi P, Vaccani A, Bianchessi S, The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci 2006;63(17):2057-66
   PubMedGoogle Scholar
• Gallotta D, Nigro P, Cotugno R, Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways. Biochem Pharmacol 2010;80:370-80
   PubMedGoogle Scholar
• Velasco G, Galve-Roperh I, Sanchez C, Cannabinoids and ceramide: two lipids acting hand-by-hand. Life Sci 2005;77:1723-31
   PubMed Web of Science ®Google Scholar
• Zacchigna S, Zentilin L, Morini M, AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo. Cancer Gene Ther 2004;11:73-80
   PubMed Web of Science ®Google Scholar
• Ramer R, Hinz B. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 2008;100(1):59-69
   PubMedGoogle Scholar
• Ramer R, Merkord J, Rohde H, Hinz B. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochem Pharmacol 2010;79(7):955-66
   PubMedGoogle Scholar
• Pisanti S, Borselli C, Oliviero O, Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J Cell Physiol 2007;211(2):495-503
   PubMedGoogle Scholar
• Portella G, Laezza C, Laccetti P, Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. FASEB J 2003;17(12):1771-3
   PubMedGoogle Scholar
• Pisanti S, Bifulco M. Endocannabinoid system modulation in cancer biology and therapy. Pharmacol Res 2009;60(2):107-16
   PubMedGoogle Scholar
• Laezza C, Malfitano AM, Proto MC, Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. Endocr Relat Cancer 2010;17(2):495-503
   PubMedGoogle Scholar
• Ramer R, Brune K, Pahl A, Hinz B. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem Biophys Res Commun 2001;286:1144-52
   PubMedGoogle Scholar
• Hinz B, Ramer R, Eichele K, R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts. Biochem Biophys Res Commun 2004;324(2):621-6
   PubMedGoogle Scholar
• Patsos HA, Greenhough A, Hicks DJ, The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. Int J Oncol 2010;37(1):187-93
   PubMedGoogle Scholar
• Van Dross RT. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes. Mol Carcinog 2009;48(8):724-32
   PubMedGoogle Scholar
• DeMorrow S, Glaser S, Francis H, Opposing action of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid raft. J Biol Chem 2007;282:13098-113
   PubMed Web of Science ®Google Scholar
• Hsu SS, Huang CJ, Cheng HH, Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicology 2007;231(1):21-9
   PubMedGoogle Scholar
• Salazar M, Carracedo A, Salanueva IJ, Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 2009;119(5):1359-72
   PubMedGoogle Scholar
• Frampton G, Coufal M, Li H, Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. Exp Cell Res 2010;316(9):1465-77
   PubMedGoogle Scholar
• Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997;74(2):129-80
   PubMed Web of Science ®Google Scholar
• Zanella MT, Ribeiro Filho FF. Emerging drugs for obesity therapy. Arq Bras Endocrinol Metabol 2009;53:271-80
   PubMedGoogle Scholar
• Izzo AA, Borrelli F, Capasso R, Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 2009;30(10):515-27
   PubMedGoogle Scholar
• Molina-Holgado F, Pinteaux E, Moore J, Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurones and glia. J Neurosci 2003;23:6470-4
   PubMed Web of Science ®Google Scholar
• Small-Howard AL, Shimoda LM, Adra CN, Turner H. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. Biochem J 2005;25:25
   Google Scholar
• Aquila S, Guido C, Santoro A, Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. Anat Rec (Hoboken) 2010;293(2):298-309
   PubMedGoogle Scholar
• Johnson JR, Burnell-Nugent M, Lossignol D, Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 2010;39(2):167-78
   PubMedGoogle Scholar
• Guzman M, Duarte MJ, Blazquez C, A pilot clinical study of D9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 2006;95:197-203
   PubMed Web of Science ®Google Scholar